PulseAugur / Brief
EN
LIVE 05:44:56

Brief

last 24h
[1/1] 221 sources

Multi-source AI news clustered, deduplicated, and scored 0–100 across authority, cluster strength, headline signal, and time decay.

  1. East Sunshine Pharmaceutical's Insulin Glargine Approved by FDA

    OpenAI has announced that a country will receive free access to ChatGPT Plus, though the specific nation was not named. Separately, a report indicates that Alibaba Cloud leads the Chinese AI cloud market with a 38.1% share in 2025. Additionally, a young individual in Yunnan gained global attention for creating AI short films with a budget of only 3,000 yuan. AI

    IMPACT OpenAI's move could expand ChatGPT Plus accessibility, while Alibaba's market lead highlights competition in the AI cloud sector.